Edition:
United States

Akers Biosciences Inc (AKR.L)

AKR.L on London Stock Exchange

130.00GBp
21 Apr 2017
Change (% chg)

0.00 (+0.00%)
Prev Close
130.00
Open
130.00
Day's High
--
Day's Low
--
Volume
4,782
Avg. Vol
3,727
52-wk High
255.00
52-wk Low
86.00

Latest Key Developments (Source: Significant Developments)

Akers Biosciences reports earnings for fiscal year 2016
Tuesday, 11 Apr 2017 07:00am EDT 

Akers Biosciences Inc : Akers Biosciences reports earnings for fiscal year 2016 .Akers Biosciences - Expect 2017 to be characterized by further growth in flagship PIFA Heparin PF/4 rapid assay product line, sales of rapid cholesterol test.  Full Article

Empery Asset Management reports 8.45 pct passive stake in Akers Biosciences
Friday, 7 Apr 2017 02:32pm EDT 

Akers Biosciences Inc :Empery Asset Management LP reports 8.45 percent passive stake in Akers Biosciences Inc, as of March 30, 2017 - sec filing.  Full Article

Akers Biosciences files for non-timely 10-K - SEC filing
Friday, 31 Mar 2017 04:13pm EDT 

Akers Biosciences Inc : Akers Biosciences Inc files for non-timely 10-K - SEC filing .Akers Biosciences Inc - unable to file 10-K due to delay experienced in completing financial statements and other disclosures in the annual report.  Full Article

Akers Biosciences announces a $2 million private placement
Thursday, 30 Mar 2017 04:25pm EDT 

Akers Biosciences Inc : Akers Biosciences announces a $2 million private placement .Akers Biosciences Inc - Akers Bio will issue 1.4 million shares at a price of $1.40 per share.  Full Article

Akers Biosciences reports preliminary unaudited earnings highlights for fiscal year 2016
Thursday, 30 Mar 2017 08:30am EDT 

Akers Biosciences Inc : Akers Biosciences reports preliminary unaudited earnings highlights for fiscal year 2016 .Akers Biosciences Inc - "expect 2017 to be characterized by further growth in our flagship PIFA heparin PF/4 rapid assay product line".  Full Article

Akers Biosciences allowed U.S. patent for Akers Wellness tests cartridge
Thursday, 16 Feb 2017 07:00am EST 

Akers Biosciences Inc - : US patent,trademark office allowed patent covering akers bio's proprietary cartridge for optical scanning device .Akers Wellness intends to start marketing oxichek™ through direct-to-consumer channels during 2017.  Full Article

Akers Biosciences files for potential stock shelf, size not disclosed
Wednesday, 16 Nov 2016 02:37pm EST 

Akers Biosciences Inc :Files for potential stock shelf; size not disclosed - sec filing.  Full Article

Akers Biosciences reports Q3 earnings
Monday, 14 Nov 2016 07:00am EST 

Akers Biosciences Inc :Akers Biosciences announces Q3 earnings.  Full Article

Akers Biosciences settles, to sell breath technology tests
Friday, 19 Aug 2016 05:19pm EDT 

Akers Biosciences Inc : Settles dispute with Chube, Thirty Six Strategies Llc , Gavin Moran, Frank Runge - SEC Filing .Co can sell all of breath technology tests worldwide, unencumbered by past or future claims by Chube under licensing agreement.  Full Article

Akers Biosciences Q2 loss before income tax $1 million
Thursday, 11 Aug 2016 07:00am EDT 

Akers Biosciences Inc : Akers Biosciences announces h1 and q2 2016 earnings .Revenue for three months ended June 30, 2016 totaled $956,486, a 1% decrease from three months ended june 30, 2015..  Full Article

More From Around the Web

BRIEF-Akers Biosciences reports earnings for fiscal year 2016

* Akers Biosciences - Expect 2017 to be characterized by further growth in flagship PIFA Heparin PF/4 rapid assay product line, sales of rapid cholesterol test Source text for Eikon: Further company coverage: